← FDA Drug Approvals (Drugs@FDA)
PLERIXAFOR
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2023-07-24
Drug application
- FDA Application #
ANDA205197- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PLERIXAFOR
- Generic name
- Plerixafor
- Active ingredients
- PLERIXAFOR
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Marketing status
- Discontinued
- Sponsor
- TEVA PHARMS USA INC
- First approval
- 2023-07-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown